Drug Trial Radar · NCT04462770
A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
Last checked: Nov 19, 2026Latest source record: Oct 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
150
Planned (sponsor's estimate)
Start
Sep 15, 2020
Primary completion
Apr 2027
Study completion May 2029
Sponsor
- Lead sponsor
- EpygenixIndustry
- Sponsor type
- Industry
- Collaborators
- Harmony Biosciences Management, Inc.
- First posted
- Jul 8, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 2 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, Phase 3, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of clemizole hydrochloride (EPX-100) as adjunctive therapy in children and adult participants with Dravet syndrome (DS).
Conditions
- Dravet Syndrome
Interventions
Clemizole HClDrug
Clemizole HCl will be administered as an oral solution.
PlaceboDrug
Flavor- and color-matching placebo will be administered as an oral solution.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change in Countable Motor Seizures Per 28 Days (CMS-28) in the Titration Plus Maintenance Periods Relative to BaselineTime frame: From Baseline up to Week 16
- European Union: Percent Change in CMS-28 in the Maintenance Period Relative to BaselineTime frame: From Baseline up to Week 16
Locations
86 sites in 11 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama · Recruiting
Arkansas Children's Hospital
Little Rock, Arkansas · Recruiting
Children's Hospital of Los Angeles
Los Angeles, California · Terminated
University of California Irvine
Orange, California · Recruiting
UCSF Medical Center
San Francisco, California · Terminated
Yale School of Medicine - Yale-New Haven Hospital
New Haven, Connecticut · Recruiting
The Nemours Foundation
Wilmington, Delaware · Terminated
Rare Disease Research FL
Kissimmee, Florida · Terminated
Pediatric Neurology and Epilepsy Specialists
Winter Park, Florida · Recruiting
Clinical Integrative Research Center of Atlanta (CIRCA)
Atlanta, Georgia · Withdrawn
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois · Terminated
Norton Children's Research Institute
Louisville, Kentucky · Recruiting
University of Michigan- Mott Children's Hospital
Ann Arbor, Michigan · Terminated
Children's Nebraska
Omaha, Nebraska · Recruiting
Northeast Regional Epilepsy Group
Hackensack, New Jersey · Withdrawn
Neurology Center for Epilepsy and Seizures
Marlboro, New Jersey · Recruiting
Weill Cornell Medical Center
New York, New York · Terminated
Northwell Health - Lenox Hill Hospital
New York, New York · Withdrawn
Duke University Health System
Durham, North Carolina · Recruiting
Science 37
Morrisville, North Carolina · Recruiting
Wake Forest Baptist Medical Center
Winston-Salem, North Carolina · Recruiting
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio · Recruiting
Cleveland Clinic
Cleveland, Ohio · Recruiting
Nationwide Children's Hospital
Columbus, Ohio · Withdrawn
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania · Recruiting
Le Bonheur Children's Hospital
Memphis, Tennessee · Terminated
Child Neurology Consultants of Austin
Austin, Texas · Recruiting
UT Southwestern/Children's Health
Dallas, Texas · Withdrawn
University of Utah
Salt Lake City, Utah · Recruiting
Seattle Children's Hospital
Seattle, Washington · Recruiting
Medical College of Wisconsin, Children's Wisconsin
Milwaukee, Wisconsin · Not yet recruiting
Fundación Para La Lucha Contra Las Enfermedades Neurológicas de La Infancia - FLENI
Buenos Aires, Argentina · Not yet recruiting
Conci Carpinella - Santa Rosa N° 748
Córdoba, Argentina · Not yet recruiting
Instituto Privado Kremer
Córdoba, Argentina · Not yet recruiting
Instituto Médico Rivarola (GIEN SRL)
San Luis, Argentina · Not yet recruiting
Hospital Universitário da Universidade Estadual de Campinas - UNICAMP
Campinas, Brazil · Not yet recruiting
Fundacao Faculdade Regional de Medicina de Sao Jose Do Rio Preto Hospital de Base - PPDS
São José do Rio Preto, Brazil · Not yet recruiting
Hospital São Paulo da Universidade Federal de Sao Paulo - Escola Paulista de Medicina UNIFESP-EPM
São Paulo, Brazil · Not yet recruiting
Instituto de Psiquiatria HC FMUSP
São Paulo, Brazil · Not yet recruiting
UBC Children's Hospital Research Institute
Vancouver, British Columbia, Canada · Recruiting
Showing 40 of 86 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.